Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl)

Details Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl) Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl)

1996-02-20

1998-12-29

Kight, John

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

424 189, A61K 5104

Patent

active

058536965

ABSTRACT:
Disclosed are certain cocaine analogs useful for imaging of cocaine receptors and dopamine receptors. Also disclosed are analogs useful for imaging diagnostics for Parkinson's disease.

REFERENCES:
patent: 3452029 (1969-06-01), Childress et al.
patent: 5128118 (1992-07-01), Carroll et al.
patent: 5268480 (1993-12-01), Kozikowski
patent: 5310912 (1994-05-01), Neumeyer et al.
patent: 5413779 (1995-05-01), Kuhar et al.
patent: 5439666 (1995-08-01), Neumeyer et al.
patent: 5493026 (1996-02-01), Elmaleh et al.
patent: 5496953 (1996-03-01), Kuhar et al.
Abstract #275, "Radioiodinated 2beta--Carbomethoxy--3beta (4-Chlorophenyl)-8-(3E-and 3Z-Iodopropen-2-yl) Nortropanes", Journal of Nuclear Medicine 33:890, 1992.
Carroll et al., "Synthesis, Ligand Binding, QSAR, and CoMFA Study . . . ", Journal of Medicinal Chemistry 34:2719-2725, 1991.
Madras et al., "N-Modified Fluorophenyltropane Analogs . . . ", Pharmcology, Biochemistry & Behavior 35:949-953, 1990.
Milius et al., "Synthesis and Receptor Binding of N-Substituted Tropane Derivatives . . . ", Journal of Medicinal Chemistry 34:1728-1731, 1991.
Boja et al. "New, Potent Cocaine Analogs: Ligand Binding and Transport Studies in Rat Striatum" European J. of Pharmacology, 184:329-332 (1990). Tropane (C-11 CFT) in Studying Dopamine Fiber Loss in a Primate Model of Parkinsonism" J. Nuclear Med. Abs., 33:946 (1992).
Canfield et al. "Autoradiographic Localization of Cocaine Binding Sites by 6:189-195 (1990).
Carroll et al. "Probes for the Cocaine Receptor. Potentially Irreversible Ligands for the Dopamine Transporter" J. Med. Chem., 35:1813-1817 (1992).
Carroll et al. "Cocaine Receptor: Biochemical Characterization and Structure-Activity Relationships of Cocaine Analogues at the Dopamine Transporter" J. Med. Chem., 35:969-981 (1992).
Carroll et al. "Synthesis, Ligand Binding, QSAR, and CoMFA Study of 3.beta.-(p-Substituted phenyl)tropane-2.beta.-carboxylic Acid Methyl Esters" J. Med. Chem., 34:2719-2725 (1991).
Elmaleh et al. "PET Imaging Probes for the Cocaine Receptors: A Validation Study in a Nonhuman Primate Model" J. Nuclear Med. Abs., 33:946 (1992).
Goodman et al. "Radioiodinated 2.beta.-Carbomethoxy-3.beta.-(4-Chlorophenyl)-8-(3E-and 3Z-Iodopropen-2-YL)Nortropanes: Synthesis of Potential Radioligands for Mapping Cocaine Receptor . . . " J. Nuclear Med. Abs., 33:890 (1992).
Kaufman et al. "Severe Depletion of Cocaine Recognition Sites Associated With the Dopamine Transporter in Parkinson's-Diseased Striatum" Synapse, 9:43-49 (1991).
Madras ".sup.11 C-WIN 35,428 for Detecting Dopamine Depletion in Mild Parkinson's Disease" Annals of Neuro., 35:376-379 (1994).
Madras et al. "N-Modified Fluorophenyltropane Analogs of Cocaine With High Affinity for Cocaine Receptors" Pharmacol. Biochem. & Behav., 35:949-953 (1990).
Meltzer et al. "Substituted 3-Phenyltropane Analogs of Cocaine: Synthesis, Inhibition of Binding at Cocaine Recognition Sites, and Positron Emission Tomography Imaging" J. Med. Chem., 36:855-862 (1993).
Milius et al. "Synthesis and Receptor Binding of N-Substituted Tropane Derivatives. High-Affinity Ligands for the Cocaine Receptor" J. Med. Chem., 34:1728-1731 (1991).
Reith et al. "Radiolabeling of Dopamine Uptake Sites in Mouse Striatum: Comparison of Binding Sites for Cocaine, Mazindol, and GBR 12935" Arch. of Pharmacol., 345:309-318 (1992).
Reith et al. "Structural Requirements for Cocaine Congeners to Interact with Dopamine and Serotonin Uptake Sites in Mouse Brain and to Induce Sterotyped Behavior" Biochem. Pharmacol., 35:1123-1129 (1986).
Isacson, "Clinical and Preclinical PET Correlates of Parkinsonism with .sup.11 C-Win 35,428" Annals of Neurology, 35:377-378 (1994).
Meyer et al. "Intravenously Administered Dopamine Transporter Site Radioligand Is Not Significantly Retained in Mouse Substantia Nigra or Other Sites Outside of Basal Ganglia" Annals of Neurology, 35:378-379 (1994).
Van der Zee et al., "A comparison of the inhibitory effects of aromatic substituted benzhydryl . . . into synaptosomal preparations of the rat brain", Neuropharmacology, 17(7), 483-90, 1978.

Affiliated with

Also associated with

Rating

Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1421317